CMS reveals 34 Medicare drugs subject to inflation rebates under IRA next quarter
The federal government has released the latest round of Medicare coinsurance savings under the Inflation Reduction Act’s rebate program.
The legislation enacted last summer requires rebates to Medicare on certain drugs with prices rising faster than the rate of inflation. A total of 34 Part B drugs will have adjusted coinsurance rates for the Oct. 1 to Dec. 31 period, resulting in savings for seniors between $1 and $618 per average dose, according to CMS, higher than last quarter’s maximum $449 per average dose despite a slightly shorter list.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.